The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...

Synthesizing brain MRI lesions is challenging due to the heterogeneity of lesion characteristics and the complexity of capturing fine-grained pathological information across MRI contrasts.

Another critical limitation is the lack of consistency across datasets and methods. Existing methods are developed independently with distinct labeling standards, inherently introducing discrepancies ...

AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...

Magnetic resonance imaging (MRI) machines can clearly view non-bony parts of the body—soft tissue such as the brain, muscles and ligaments—as well as detect tumors, making it possible to diagnose many ...

You are at the healthcare provider’s office, and they tell you that you need an MRI scan with contrast dye. You might feel a little nervous about having chemicals put into your body. You might wonder, ...

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...